enteric aspirin

Generic: aspirin

Labeler: chain drug marketing association inc
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name enteric aspirin
Generic Name aspirin
Labeler chain drug marketing association inc
Dosage Form TABLET, DELAYED RELEASE
Routes
ORAL
Active Ingredients

aspirin 325 mg/1

Manufacturer
CHAIN DRUG MARKETING ASSOCIATION INC

Identifiers & Regulatory

Product NDC 63868-898
Product ID 63868-898_ac2d47b0-2641-4474-a8d3-bc1d362edbad
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M013
Marketing Start 1992-12-14
Marketing End 2026-09-30

Pharmacologic Class

Established (EPC)
nonsteroidal anti-inflammatory drug [epc] platelet aggregation inhibitor [epc]
Mechanism of Action
cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs]
Physiologic Effect
decreased prostaglandin production [pe] decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 63868898
Hyphenated Format 63868-898

Supplemental Identifiers

RxCUI
198467
UPC
0635515983045
UNII
R16CO5Y76E
NUI
N0000000160 N0000008836 M0001335 N0000175722 N0000175578 N0000008832

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name enteric aspirin (source: ndc)
Generic Name aspirin (source: ndc)
Application Number M013 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 325 mg/1
source: ndc
Packaging
  • 1 BOTTLE in 1 CARTON (63868-898-10) / 100 TABLET, DELAYED RELEASE in 1 BOTTLE
source: ndc

Packages (1)

63868-898-10 1 BOTTLE in 1 CARTON (63868-898-10) / 100 TABLET, DELAYED RELEASE in 1 BOTTLE

Ingredients (1)

aspirin (325 mg/1)

Linked Drug Pages (1)

Enteric Aspirin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "ac2d47b0-2641-4474-a8d3-bc1d362edbad", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "upc": ["0635515983045"], "unii": ["R16CO5Y76E"], "rxcui": ["198467"], "spl_set_id": ["a791d664-99fe-4cba-95cf-f49baedde326"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["CHAIN DRUG MARKETING ASSOCIATION INC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (63868-898-10)  / 100 TABLET, DELAYED RELEASE in 1 BOTTLE", "package_ndc": "63868-898-10", "marketing_end_date": "20260930", "marketing_start_date": "19921214"}], "brand_name": "Enteric Aspirin", "product_id": "63868-898_ac2d47b0-2641-4474-a8d3-bc1d362edbad", "dosage_form": "TABLET, DELAYED RELEASE", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "63868-898", "generic_name": "Aspirin", "labeler_name": "CHAIN DRUG MARKETING ASSOCIATION INC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Enteric Aspirin", "active_ingredients": [{"name": "ASPIRIN", "strength": "325 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_end_date": "20260930", "marketing_start_date": "19921214"}